[
  {
    "uuid": "5c42424af618d24abc3fc154b0d9aa830bc0b631",
    "url": "https://mx.advfn.com/bolsa-de-valores/noticias/95895018/metastatic-colorectal-cancer-market-poised-for-exp",
    "ord_in_thread": 0,
    "author": "PR Newswire (US)",
    "published": "2025-04-23T21:33:34Z",
    "title": "Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight",
    "text": "The metastatic colorectal cancer (mCRC) market is experiencing significant growth, driven by advancements in targeted therapies, immunotherapies, and personalized medicine. The increasing prevalence of colorectal cancer, along with growing awareness of early diagnosis and treatment options, is fueling demand for innovative treatments.\nLAS VEGAS , April 23, 2025 /PRNewswire/ -- Colorectal cancer (CRC) ranks as the third most prevalent cancer, with metastasis being the leading cause of mortality among affected patients. The liver and peritoneum are the most frequent sites of distant spread. For most individuals, metastatic CRC (mCRC) remains largely incurable, with common metastatic locations including the liver, lungs, lymph nodes, and peritoneum.\nSeen in approximately 45% CRC patients, KRAS mutations significantly influence the prognosis and treatment outcomes. These mutations are associated with a more aggressive disease course, resistance to chemotherapy and targeted therapies, and overall poorer survival rates.\nIn 2024, the incidence of metastatic colorectal cancer was around 294K cases across the seven major markets, with the United States reporting the highest incidence. This number is expected to rise by 2034. Surgical intervention is the mainstay for resectable CRC, while unresectable cases are typically managed with chemotherapy, radiotherapy, and immunotherapy. These conventional therapies, however, often lack specificity and can harm healthy cells, leading to additional health complications.\nThe treatment paradigm for mCRC involves multiple lines of therapy. First-line (1L) metastatic colorectal cancer treatments include combination chemotherapy regimens such as FOLFOX, FOLFIRI, and CAPEOX , alongside anti-angiogenic agents and targeted therapies like VECTIBIX and ERBITUX , with or without chemotherapy. KEYTRUDA and BRAFTOVI (in combination with ERBITUX and mFOLFOX6) are also approved for use in the first line. In the second-line (2L) setting, treatment options expand to include OPDIVO (¬± YERVOY), JEMPERLI, TUKYSA (¬± Trastuzumab), LONSURF (¬± Bevacizumab), and KRAZATI plus ERBITUX . For third-line (3L) therapy, specific agents such as STIVARGA and FRUZAQLA are utilized.\nLearn more about the metastatic colorectal cancer treatment landscape @ Metastatic Colorectal Cancer Drugs Market\nFRUZAQLA (fruquintinib) is a once-daily oral capsule developed by Takeda Pharmaceuticals . It is a kinase inhibitor approved for adult patients with metastatic colorectal cancer who have previously been treated with chemotherapy regimens including fluoropyrimidine, oxaliplatin, and irinotecan, as well as anti-VEGF therapy and, for RAS wild-type patients, anti-EGFR therapy. FRUZAQLA works by selectively targeting and inhibiting VEGFR-1, -2, and -3, thereby disrupting VEGF-driven blood vessel formation and tumor growth.\nThe FDA approved FRUZAQLA for previously treated mCRC in November 2023 , followed by the European Commission in June 2024 , and Japan in September 2024‚Äîmarking it as the first new targeted therapy for mCRC in more than ten years in the Japanese market.\nOPDIVO QVANTIG (nivolumab and hyaluronidase-nvhy) is indicated for adult patients with MSI-H or dMMR mCRC that has progressed after prior treatment with fluoropyrimidine, oxaliplatin, and irinotecan. It can be used as a standalone treatment or following prior combination therapy with intravenous nivolumab and ipilimumab. This drug works by blocking the PD-1 receptor, preventing its interaction with PD-L1 and PD-L2 to boost immune system activity against cancer cells.\nIn December 2024 , the FDA approved OPDIVO QVANTIG as a subcutaneous injection for mCRC, making it the first PD-1 inhibitor available in this form. This new route of administration offers quicker treatment delivery‚Äîjust 3 to 5 minutes‚Äîcompared to the traditional 30-minute intravenous infusion of OPDIVO.\nTo know more about metastatic colorectal cancer treatments, visit @ Metastatic Colorectal Cancer Aggressive Treatment\nDespite several advancements, the metastatic colorectal cancer drug market remains highly competitive, with significant unmet needs for durable and long-term treatment responses. Ongoing research into investigational agents like amivantamab, zanzalintinib, and vactosertib highlights the push for more effective, resistance-targeting, and tumor microenvironment-modifying therapies, signaling a dynamic and evolving future for mCRC treatment.\nKey companies such as Johnson & Johnson Innovative Medicine, Shanghai Henlius Biotech, Inspirna, Treos Bio, Cardiff Oncology, Agenus, Leap Therapeutics, Arcus Biosciences, Enterome, Tizona Therapeutics, Innovative Cellular Therapeutics , and others are currently active in the metastatic colorectal cancer drug market.\nDiscover which therapies are expected to grab major metastatic colorectal cancer drug market share @ Metastatic Colorectal Cancer Market Report\nAmivantamab is a bispecific antibody designed to target specific genetic alterations, especially EGFR exon 20 insertion mutations. Its dual mechanism focuses on inhibiting both the Epidermal Growth Factor Receptor (EGFR) and the MET receptor‚Äîtwo key players in cancer cell growth and survival. By binding to these receptors, amivantamab interferes with their signaling pathways, helping to overcome resistance that tumors often develop to other treatments.\nThis dual targeting not only suppresses tumor cell growth but also enhances the body's immune response, leading to greater cancer cell destruction. The drug is currently in Phase III clinical trials for treating metastatic colorectal cancer (mCRC).\nZanzalintinib (XL-092) is a third-generation oral tyrosine kinase inhibitor that blocks several cancer-related receptor tyrosine kinases, including VEGF receptors, MET, AXL, and MER. These kinases play a role in normal cell function as well as pathological processes like cancer development, metastasis, angiogenesis, and resistance to therapies such as immune checkpoint inhibitors. Developed by Exelixis , Zanzalintinib builds on the company's experience with cabozantinib, aiming to improve attributes like pharmacokinetic half-life. It is also in Phase III clinical trials for mCRC.\nDKN-01 is a humanized monoclonal antibody that targets the DKK1 protein and is being developed for treating esophagogastric, gynecologic, and colorectal cancers. Initial findings from Part A of the DeFianCe trial were shared at the 2024 ASCO Gastrointestinal Cancers Symposium. Enrollment for Part B of the DeFianCe trial (NCT05480306) concluded in September 2024 . This Phase II, randomized, open-label, controlled study is assessing DKN-01 in combination with bevacizumab and chemotherapy as a second-line treatment for advanced colorectal cancer in patients previously treated with one systemic therapy. The study enrolled 188 patients, with early results anticipated by mid-2025.\nDiscover more about drugs for metastatic colorectal cancer in development @ Metastatic Colorectal Cancer Clinical Trials\nThe anticipated launch of these emerging metastatic colorectal cancer treatments are poised to transform the market landscape in the coming years. As these cutting-edge therapies continue to mature and gain regulatory approval, they are expected to reshape the metastatic colorectal cancer market landscape, offering new standards of care and unlocking opportunities for medical innovation and economic growth.\nDelveInsight estimates that the market size for metastatic colorectal cancer in the 7MM is expected to grow from USD 13 billion in 2024 with a significant CAGR by 2034. This growth is fueled by advancements in precision medicine, including targeted therapies and immunotherapies, which have shown promise in improving patient outcomes.\nDelveInsight's latest published market report titled as Metastatic Colorectal Cancer Market Insight, Epidemiology, and Market Forecast ‚Äì 2034 will help you to discover which market leader is going to capture the largest market share. The report provides comprehensive insights into the metastatic colorectal cancer country-specific treatment guidelines, patient pool analysis, and epidemiology forecast to help understand the key opportunities and assess the market's underlying potential. The metastatic colorectal cancer market report proffers epidemiological analysis for the study period 2020‚Äì2034 in the 7MM, segmented into:\nTotal Incident Cases of CRC Gender-specific Cases of CRC Age-specific Cases of CRC Tumor Location-specific Cases of CRC Stage-specific Cases of CRC Total Incident Cases of mCRC Mutation Type-specific Cases of mCRC Total Treated Cases of mCRC by Line of Therapy The report provides an edge while developing business strategies by understanding trends shaping and driving the 7MM metastatic colorectal cancer market. Highlights include:\n10-year Forecast 7MM Analysis Epidemiology-based Market Forecasting Historical and Forecasted Market Analysis upto 2034 Emerging Drug Market Uptake Peak Sales Analysis Key Cross Competition Analysis Industry Expert's Opinion Access and Reimbursement Download this metastatic colorectal cancer market report to assess the epidemiology forecasts, understand the patient journeys, know KOLs' opinions about the upcoming treatment paradigms, and determine the factors contributing to the shift in the metastatic colorectal cancer market. Also, stay abreast of the mitigating factors to improve your market position in the metastatic colorectal cancer therapeutic space.\nRelated Reports\nMetastatic Colorectal Cancer Pipeline\nMetastatic Colorectal Cancer Pipeline Insight ‚Äì 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key metastatic colorectal cancer companies, including Shanghai Henlius Biotech, Eisai Inc., Treos Bio, AUM Biosciences, Leap Therapeutics, Inc., Hoffmann-La Roche, Replimune, Qilu Pharmaceutical, Lutris Pharma, Ipsen, Bold Therapeutics, Pacylex Pharmaceuticals, FivepHusion, SystImmune, Inspirna, Inc., Sapience Therapeutics, Exelixis, Daiichi Sankyo, Hutchmed, Merus N.V., REVOLUTION Medicines, Pure Tech Health, Medicenna Therapeutics, Inc., Verastem Inc., Next Cure Inc., Isofol Medical, Zentalis Pharmaceuticals, Oncoinvent, KaryoPharm Therapeutics, Aadi Biosciences, among others.\nMetastatic Colorectal Cancer Market\nMetastatic Colorectal Cancer Market Insights, Epidemiology, and Market Forecast ‚Äì 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key metastatic colorectal cancer companies, including Johnson & Johnson Innovative Medicine, Shanghai Henlius Biotech, Inspirna, Treos Bio, Cardiff Oncology, Agenus, Leap Therapeutics, Arcus Biosciences, Enterome, Tizona Therapeutics, Innovative Cellular Therapeutics, among others.\nColorectal Cancer Market\nColorectal Cancer Market Insights, Epidemiology, and Market Forecast ‚Äì 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key colorectal cancer companies, including Mirati Therapeutics, Exelixis, Enterome, Arcus Biosciences, Lyell Immunopharma, AstraZeneca, Novartis Pharmaceuticals, Surgimab, Numab Therapeutics, SOTIO Biotech, Amgen, Sichuan Baili Pharmaceutical, Qilu Pharmaceutical, Bristol-Myers Squibb, NGM Biopharmaceuticals, Takeda, PureTech, Pfizer, Kezar Life Sciences, Salubris Biotherapeutics, among others.\nColorectal Cancer Pipeline\nColorectal Cancer Pipeline Insight ‚Äì 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key colorectal cancer companies, including Exelixis, Mirati Therapeutics, Merck Sharp & Dohme LLC, Daiichi Sankyo Company, Inspirna, Lyell Immunopharma, Genentech, Cantargia AB, Arcus Biosciences, Inc, Neogap Therapeutics AB, Criterium, Inc, Daiichi Sankyo, Inc, Bristol-Myers Squibb, Celyad Oncology SA, Pfizer, Akeso, Menarini Group, Elpiscience (Suzhou) Biopharma, Ltd., BeyondBio Inc., Shanghai Henlius Biotech, Rottapharm Biotech, Innovative Cellular Therapeutics Inc., BioNTech SE, among others.\nAbout DelveInsight\nDelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve .\nContact Us\nShruti Thakur\ninfo@delveinsight.com\n+14699457679\nLogo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg\nView original content:https://www.prnewswire.com/news-releases/metastatic-colorectal-cancer-market-poised-for-expansion-across-the-7mm-during-the-forecast-period-20252034-as-breakthrough-therapies-gain-traction--delveinsight-302435372.html\nSOURCE DelveInsight Business Research, LLP\nCopyright 2025 PR Newswire",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology",
      "Human Interest"
    ],
    "topics": [
      "Health->cancer",
      "Health->health treatment and procedure",
      "Science and Technology->medical research",
      "Science and Technology->biomedical science"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
      "https://www.prnewswire.com/news-releases/metastatic-colorectal-cancer-market-poised-for-expansion-across-the-7mm-during-the-forecast-period-20252034-as-breakthrough-therapies-gain-traction--delveinsight-302435372.html",
      "https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015",
      "https://prnewswire.com/news-releases/metastatic-colorectal-cancer-market-poised-for-expansion-across-the-7mm-during-the-forecast-period-20252034-as-breakthrough-therapies-gain-traction--delveinsight-302435372.html",
      "https://www.static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015"
    ],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": [
        {
          "name": "KRAS",
          "sentiment": "none",
          "tickers": []
        }
      ]
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": "5c42424af618d24abc3fc154b0d9aa830bc0b631",
      "first_syndicated": true
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-24T00:33:34.791+03:00",
    "updated": "2025-04-24T00:33:34.791+03:00"
  },
  {
    "uuid": "bac786794cf701345bccf301febeeb2c94c26a88",
    "url": "https://markets.financialcontent.com/stocks/article/kisspr-2024-3-14-gameday-mens-health-south-fort-wayne-opens-new-clinic",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Prodigy",
    "published": "2024-03-14T18:57:00Z",
    "title": "Gameday Men‚Äôs Health South Fort Wayne Opens New Clinic | FinancialContent Business Page",
    "text": "03/14/2024, Fort Wayne, IN // PRODIGY: Feature Story //\nGameday Men‚Äôs Health South Fort Wayne has opened its new clinic for the benefit of men in Fort Wayne, IN, and surrounding areas, who can now get its top-notch and customized treatments for low testosterone, erectile dysfunction, etc. in a comfortable environment.\nAccording to studies, over 40% of men experience low testosterone by the age of 40, and 60% have to deal with erectile dysfunction at some point in their lives. Andropause, characterized by symptoms like poor quality of sleep, brain fog, mood swings, and reduced focus and concentration, adds to these problems. Testosterone replacement therapy or TRT offers men respite from the impact of andropause.\nGameday Men‚Äôs Health South Fort Wayne This is exactly where Gameday Men‚Äôs Health has built its expertise. Having helped men across the country, the leading men‚Äôs health clinic understands that all individuals have unique requirements and health goals. As a result, it focuses on offering customized treatment solutions for men in a comfortable environment.\nSuch dedication to personalized and innovative care extends to Gameday Men‚Äôs Health South Fort Wayne . Equipped with modern, state-of-the-art facilities, which include comfortable seating and LED TV screens, it has created a man cave‚Äìlike environment for men. The leading testosterone replacement therapy clinic also prioritizes their convenience every step of the way.\nMen of Fort Wayne, IN, and surrounding areas looking for low T and erectile dysfunction treatments can reach out to the newly opened clinic. It has made the process for appointments quick, efficient, and convenient. Its team of certified healthcare professionals offers a free initial consultation to address inquiries and match their treatment plans with individual health goals into account.\nOn-site lab testing is also a part of the initial consultation. It ensures that men have their blood work results in as little as 15 minutes. Based on the results, Gameday Men‚Äôs Health South Fort Wayne offers low T treatments tailored to their specific requirements. The process of getting weekly injections is also quite straightforward. Men can be in and out of the clinic within 10 minutes.\nSome of the benefits of these innovative, customized treatments for men include enhanced sex drive, better erectile quality, improved sleep, proper immune function, motivation and confidence, and so much more.\nTo learn more about the newly opened clinic and its services and to book a consultation, visit https://gamedaymenshealth.com/south-fort-wayne/ .\nAbout Gameday Men‚Äôs Health\nThe premier men‚Äôs health clinic has made its mark with men across the country with its customized and innovative treatments for low testosterone, erectile dysfunction, etc., in a comfortable and welcoming environment.\n###\nMedia Contact\nGameday Men‚Äôs Health South Fort Wayne\nAddress: 7230 Engle Rd Suite 304, Fort Wayne, IN 46804\nPhone: +12603444146\nWebsite: https://gamedaymenshealth.com/south-fort-wayne/\nnewsroom: news.38digitalmarket.com\nSource: 38 Digital Market News\nRelease ID: 956181 Source published by Submit Press Release >> Gameday Men‚Äôs Health South Fort Wayne Opens New Clinic",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Economy, Business and Finance",
      "Human Interest",
      "Health"
    ],
    "external_links": [
      "https://maps.app.goo.gl/BjrN17jDjMm9v8G19",
      "https://gamedaymenshealth.com/south-charlotte/",
      "https://gamedaymenshealth.com/south-fort-wayne/",
      "https://im.submitmypressrelease.com/info/956181",
      "https://tracking.newsrpm.com/pixel?slug=kisspr-2024-3-14-gameday-mens-health-south-fort-wayne-opens-new-clinic",
      "https://newsroom.submitmypressrelease.com/2024/03/14/gameday-mens-health-south-fort-wayne-opens-new-clinic_956181.html",
      "https://www.gamedaymenshealth.com/south-fort-wayne/",
      "https://www.newsroom.submitmypressrelease.com/2024/03/14/gameday-mens-health-south-fort-wayne-opens-new-clinic_956181.html",
      "https://tracking.newsrpm.com/pixel",
      "https://gamedaymenshealth.com/south-charlotte",
      "https://www.im.submitmypressrelease.com/info/956181",
      "https://www.tracking.newsrpm.com/pixel?slug=kisspr-2024-3-14-gameday-mens-health-south-fort-wayne-opens-new-clinic",
      "https://gamedaymenshealth.com/south-fort-wayne",
      "https://www.maps.app.goo.gl/BjrN17jDjMm9v8G19",
      "https://www.gamedaymenshealth.com/south-charlotte/"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [
        {
          "name": "gameday men‚Äôs health south fort wayne opens new clinic",
          "sentiment": "neutral"
        },
        {
          "name": "men‚Äôs health south fort wayne",
          "sentiment": "neutral"
        },
        {
          "name": "gameday men‚Äôs health",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "fort wayne",
          "sentiment": "none"
        },
        {
          "name": "south fort wayne",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-03-15T00:21:09.157+02:00",
    "updated": "2024-03-15T00:21:09.157+02:00"
  },
  {
    "uuid": "c9a5d3caac1fa729c4218caef654afb299c5b91c",
    "url": "https://www.newsbreak.com/beach-radio-520708/3842534219041-nj-wildfire-season-takes-off-with-suspicious-blaze-among-230-fires-so-far",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Dan Alexander",
    "published": "2025-03-06T01:25:00Z",
    "title": "NJ wildfire season takes off with 'suspicious' blaze among 230 fires so far - NewsBreak",
    "text": "New Jersey\nNJ wildfire season takes off with ‚Äòsuspicious‚Äô blaze among 230 fires so far\nBy Dan Alexander,\n1 hours agoüî• A fallen powerline sparked the Hopewell wildfire. üî• The Forest Fire Service is joining the investigation of the Pennsville wildfire. üî• There have already been 230 wildfires in NJ this year. NOTE: The story has been updated to show the correct number of wildfires so far...\n1",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Environment",
      "Disaster and Accident",
      "Social Issue"
    ],
    "topics": [
      "Environment->natural resources",
      "Environment->climate change",
      "Environment->environmental pollution",
      "Disaster and Accident->fire",
      "Disaster and Accident->natural disaster",
      "Social Issue->demographics",
      "Social Issue->social problem",
      "Social Issue->social condition"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "Dan Alexan",
          "sentiment": "negative"
        }
      ],
      "locations": [],
      "organizations": [
        {
          "name": "Forest Fire Service",
          "sentiment": "none",
          "tickers": []
        }
      ]
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-03-06T04:55:09.737+02:00",
    "updated": "2025-03-06T04:55:09.737+02:00"
  },
  {
    "uuid": "b0266f5b8220d1b801b86c2f34b70f2e06835c09",
    "url": "https://www.meneame.net/story/alvise-vota-contra-recortar-privilegios-eurodiputados-enviar/c060",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "MaKaNaS",
    "published": "2024-10-24T19:50:00Z",
    "title": "#60 Alvise vota en contra de recortar los privilegios de los eurodiputados y de enviar ayuda econ√≥mica a Ucrania",
    "text": "Portada\nmis comunidades\notras secciones\n[#4](c4#c-4)\nPues ya ves, los hay que le defienden.\n[#4](c4#c-4) no voy a negar la mayor de que sea un mamarracho pero a nadie le sorprende que la noticia no te cuente que han votado los dem√°s?\n[#13](c13#c-13) No. ¬øSi buscas la noticia sobre que ha votado la ultraderecha europea, te sorprende que no hablen de alvise?\nCada panfleto busca la noticia en su caladero, no en el de los demas.\n[#13](c13#c-13) tienes raz√≥n, por cierto c√≥mo se llamaba el partido que mont√≥?\n[#13](c13#c-13) Los dem√°s consiguieron llegar ah√≠ con la promesa de que se \"acab√≥ la fiesta\"?\n[#4](c4#c-4) cuanto da√±o hizo el chiquilicuatre en Eurovisi√≥n. Ahora mandamos el festival del humor al parlamento europeo. La √∫nica diferencia es que a este le pagamos y le seguiremos pagando una buena temporada\n[#4](c4#c-4) Pero si tampoco ha sorteado el sueldo de Octubre!!!!\n[#1](c1#c-1) Se Acab√≥ La Fiesta (para los dem√°s)\n[#2](c2#c-2) Hola soy Errej√≥n\n[#2](c2#c-2) √âl ahora que ha llegado a la fiesta, no quiere que se acabe. Para √©l acaba de comenzar la fiesta. Dietas por aqu√≠, dietas por all√°...\n[#2](c2#c-2) Sin tener ni puta idea de nada, porque ni sigo a este t√≠o, ni s√© lo que dice ni nada...pero...con lo que pas√≥ con Podemos y la desinformaci√≥n sobre ellos hasta el punto de que los odia todo el mundo por cosas como comprar un chalet o financiaciones ilegales que no existieron...¬øRealmente el Alvise este es tan malo o se est√°n encargando de soltar bulos a diario para joderle? POrque se supone que su lei motif era acabar con la corrupci√≥n, y vaya, qu√© casualidad, cada d√≠a tres o cuatro noticias de lo hijoputa que es √©l, y lo corrupto, y lo mentiroso.\nA ver si los bulos de los del otro lado nos los comemos todos, y s√≥lo desconfiamos cuando hablan mal del que hemos votado ese a√±o...\nEs cutre y z√°fio, se lleva m√°s con el discurso populista y va y lo jode...\nPero como tiene el electorado que tiene, al final solo van a quedar 799.999 de los 800.000 votos que saco. Con esto ha perdido uno de sus votos, seguro...\n[#6](c6#c-6) Maravillosos Carlos Puebla y la canci√≥n.\n[#33](c33#c-33) Ya ves, sin embargo nuestros √≠nclitos ciudadanos de derechas no se despeinan cuendo se trata de mandar armas y homenajear a genocidas sionistas.\n\"No es tiempo para demagogias baratas\" agreg√≥. Y habr√° alg√∫n gilipollas que se la trague entera\nHombre, es que el no es tonto. Los que son tontos ya sabemos quienes son, sus votantes.\n[#40](c40#c-40) Te equivocas. Lleva tres sorteos.\nhttps://alvisecumpliendo.com/ganadores\n[#9](c9#c-9) a quien no le a pasado que va a una fiesta para buscar a alguien y sin ganas de liarse y acaba siendo el √∫ltimo en acabar el fiest√≥n\n[#0](c0#c-0) Pulso en la imagen sobre alvise y me sale errej√≥n\nNo habia oido al subnormal este hablando de turbocanceres\nhttps://www.lasexta.com/programas/al-rojo-vivo/joaquin-castellon-desmonta-alvise-perez-decir-que-vacunas-provocan-turbo-cancer-oncologos-dicen-que-eso-existe_20241024671a2641d0584100016f3daa.html\n[#10](c10#c-10) Hombre, dietas precisamente al chaval le hacen falta porque √∫ltimamente se ha puesto bastante gordo.\n[#10](c10#c-10) Bueno, y porque los datos personales de m√°s de 100.000 personas tambi√©n valen una pasta.\nPara un cosa que hace bien! Que los intereses expansivos de los USA, se lo paguen ellos mismos, y no la UE. M√°s a√∫n cuando sea verdad o como cabeza de turco, han reventado una infraestructura energ√©tica estrat√©gica de la UE, pero la que pasa por su territorio la tienen como oro en pa√±o.\n[#41](c41#c-41) Sus ac√≥litos dicen que la noticia es falsa. que ha votado a favor de recortar privilegios.\nHay que esperar\nNo quiere que se le acabe la fiesta.\nSe le Alvisto el plumero. Bueno todo el mundo le vi√≥ el plumero menos sus ac√≥litos.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Politics",
      "Social Issue"
    ],
    "ai_allow": true,
    "canonical": false,
    "webz_reporter": false,
    "external_links": [
      "https://alvisecumpliendo.com/ganadores",
      "https://www.lasexta.com/programas/al-rojo-vivo/joaquin-castellon-desmonta-alvise-perez-decir-que-vacunas-provocan-turbo-cancer-oncologos-dicen-que-eso-existe_20241024671a2641d0584100016f3daa.html",
      "https://www.alvisecumpliendo.com/ganadores",
      "https://lasexta.com/programas/al-rojo-vivo/joaquin-castellon-desmonta-alvise-perez-decir-que-vacunas-provocan-turbo-cancer-oncologos-dicen-que-eso-existe_20241024671a2641d0584100016f3daa.html"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-10-25T00:54:30.811+03:00",
    "updated": "2024-10-25T00:54:30.811+03:00"
  },
  {
    "uuid": "25c448a9f9b11e3dcc3a75e70935db63e2bfddb4",
    "url": "https://www.c114.com.cn/news/127/a1284633.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "C114ÈÄö‰ø°ÁΩë",
    "published": "2025-03-06T03:56:00Z",
    "title": "‰∏≠ÂõΩÁßªÂä®„ÄÅÈòøÈáå‰∫ëÂíå‰∏≠ÂÖ¥ÈÄöËÆØËÅîÂêàÊâìÈÄ†ÁöÑËÉΩÂäõÂºÄÊîæËß£ÂÜ≥ÊñπÊ°àËç£Ëé∑GSMA GLOMO \"Open GatewayÊåëÊàòÂ•ñ\" - ‰∏≠ÂÖ¥ - C114ÈÄö‰ø°ÁΩë",
    "text": "„ÄêË•øÁè≠ÁâôÔºåÂ∑¥Â°ûÁΩóÈÇ£Ôºå3Êúà6Êó•„ÄëÂú®‰∏ñÁïå ÁßªÂä®ÈÄö‰ø° Â§ß‰ºöÔºàMWC25Â∑¥Â°ûÁΩóÈÇ£ÔºâÊúüÈó¥ÔºåÁî± ‰∏≠ÂõΩÁßªÂä® „ÄÅÈòøÈáå‰∫ëÂíå ‰∏≠ÂÖ¥ ÈÄöËÆØËÅîÂêàÊâìÈÄ†ÁöÑAaaS Open GatewayËÉΩÂäõÂºÄÊîæËß£ÂÜ≥ÊñπÊ°àËç£Ëé∑GSMAÂÖ®ÁêÉÁßªÂä®Â§ßÂ•ñÔºàGLOMOÔºâ‚ÄúOpen GatewayÊåëÊàòÂ•ñ‚ÄùÔºåÊ†áÂøóÁùÄOpen GatewayÂú®‰∏ªË¶ÅË°å‰∏öÁöÑÁ§∫ËåÉÊÄßÂú∫ÊôØÂ∑≤ÁªèÂæóÂà∞ËßÑÊ®°ÂïÜÁî®Ôºå‰∏≠ÂõΩÁßªÂä®Êê∫ÊâãÂêà‰Ωú‰ºô‰º¥Ë∑µË°åGSMA Open GatewayÂÄ°ËÆÆÁöÑÂä™ÂäõÂæóÂà∞‰∫ÜÂÖ®ÁêÉ‰∫ß‰∏öÁöÑÈ´òÂ∫¶ËÆ§ÂèØ„ÄÇ\n‰∏≠ÂõΩÁßªÂä®ÊòØÊúÄÊó©Âä†ÂÖ•GSMA Open GatewayÂÖ®ÁêÉÂÄ°ËÆÆÁöÑ ËøêËê•ÂïÜ ‰πã‰∏ÄÔºåËøëÂπ¥Êù•ÁßØÊûÅË∑µË°åOpen GatewayÂèëÂ±ïÁêÜÂøµÔºåÂª∫Êàê‰∫ÜÂÖ®ÁêÉÊúÄÂ§ßÁöÑOpen GatewayÂπ≥Âè∞ÔºåÂØπÂÜÖËµãËÉΩËá™Êúâ‰∏öÂä°ÔºåÂØπÂ§ñ‰∏çÊñ≠ÊãìÂ±ïÂ∫îÁî®Âú∫ÊôØÔºå‰∏∞ÂØåOpen GatewayÂ∫îÁî®ÁîüÊÄÅ„ÄÇ‰∏≠ÂõΩÁßªÂä®ËÅîÂêà‰∏≠ÂÖ¥ÈÄöËÆØÂü∫‰∫éCAMARA APIËßÑËåÉÊâìÈÄ†ÁöÑQoDÔºàQuality on DemandÔºâAPIÔºåÁéáÂÖàÈÄöËøáOpen GatewayÂ∑•‰ΩúÁªÑ63È°πÊäÄÊúØ ÊµãËØï ÔºåÂπ∂ÂÆûÁé∞ËêΩÂú∞ÈÉ®ÁΩ≤„ÄÇ\n‰∏≠ÂõΩÁßªÂä®„ÄÅÈòøÈáå‰∫ëÂíå‰∏≠ÂÖ¥ÈÄöËÆØËÅîÂêàÊâìÈÄ†ÁöÑËÉΩÂäõÂºÄÊîæËß£ÂÜ≥ÊñπÊ°àÔºå Êï¥Âêà ‰∫ÜÂêÑÊñπÂú®ÈÄö‰ø° ÁΩëÁªú „ÄÅÈáëËûçÁßëÊäÄÁ≠âÈ¢ÜÂüüÁöÑ‰ºòÂäøÔºå‰æùÊâò‰∏≠ÂõΩÁßªÂä®Open GatewayÂπ≥Âè∞ÔºåÊö®ÁΩëÁªú‰∫ã‰∏öÈÉ®ËøêËê•ÁöÑCT‰∏≠Âè∞‰∏≠‚Äú QoS Âä†ÈÄüËÉΩÂäõ‚ÄùÔºåÂÆûÁé∞‰∫ÜÂØπ ÁßªÂä®ÊîØ‰ªò Á≠âÂ∫îÁî®ÁöÑÁΩëÁªúË¥®Èáè‰øùÈöúÔºåËá¥Âäõ‰∫é‰∏∫Áî®Êà∑ÊâìÈÄ†Êõ¥ÂèãÂ•Ω„ÄÅÊõ¥È´òÊïà„ÄÅÊõ¥ÂÖ∑ÂàõÊñ∞ÊÄßÁöÑ 5G ÁΩëÁªú‰∏öÂä°‰ΩìÈ™å„ÄÇ\nÊîØ‰ªòÂÆùÊòØÂÖ®ÁêÉÊúÄÂ§ßÁöÑÊîØ‰ªòÂπ≥Âè∞‰πã‰∏ÄÔºåÈÄöËøáÈòøÈáå‰∫ëÊé•ÂÖ•‰∏≠ÂõΩÁßªÂä®Open GatewayÂπ≥Âè∞„ÄÇÂΩìÁî®Êà∑ËøõÂÖ•Âº±ÁΩëÁªúË¶ÜÁõñÂå∫Âüü‰ΩøÁî®ÊîØ‰ªòÊúçÂä°Êó∂ÔºåÈòøÈáå‰∫ëË∞ÉÁî®API‰ª•ÊèêÈ´òÊó†Á∫øÁΩëÁªúÊÄßËÉΩÔºåÂ§ßÂ§ßÂáèÂ∞ë‰ªòÊ¨æ‰∫§ÊòìÊó∂Èó¥ÂíåÈôç‰ΩéÊîØ‰ªòÊïÖÈöúÁéáÔºåÊèêÂçá‰∫ÜÁî®Êà∑ÊîØ‰ªò‰ΩìÈ™å„ÄÇ\nÊú™Êù•Ôºå‰∏≠ÂõΩÁßªÂä®Â∞ÜÁªßÁª≠Êê∫Êâã‰∫ß‰∏öÂêà‰Ωú‰ºô‰º¥ÔºåÊåÅÁª≠Ë¥°ÁåÆÊõ¥Â§öËÉΩÂäõAPIÂíåÁ§∫ËåÉÊÄßÂ∫îÁî®Âú∫ÊôØÔºåÊé®Ëøõ5GÂïÜ‰∏öÂåñÂèëÂ±ïÔºåÂä†ÈÄüOpen GatewayÂÖ®ÁêÉÁîüÊÄÅÁπÅËç£„ÄÇ\nOpen GatewayËÆ°ÂàíÊòØGSMAÊé®Âä®ËÉΩÂäõÂºÄÊîæÂÖ®ÁêÉÂåñÁöÑÈáçË¶ÅÂÄ°ËÆÆÔºåËØ•ËÆ°ÂàíÊòØ‰∏Ä‰∏™ÈÄöÁî®ÂºÄÊîæÁΩëÁªúÂ∫îÁî®Á®ãÂ∫èÂèØÁºñÁ®ãÊé•Âè£ÔºàAPIÔºâÊ°ÜÊû∂Ôºå‰∏∫ÂÖ®ÁêÉ‰ºÅ‰∏öÂ∫îÁî®‰∏éÂºÄÂèëËÄÖÊèê‰æõÂØπËøêËê•ÂïÜÁΩëÁªúËÉΩÂäõÁöÑÈÄöÁî®ËÆøÈóÆËÉΩÂäõ„ÄÇËøô‰∫õÂäüËÉΩÊòØÈÄöËøáCAMARAÊ°ÜÊû∂‰∏ãÁöÑÂÖ®ÁêÉÊ†áÂáÜÂåñAPIÈÉ®ÁΩ≤ÁöÑ-CAMARAÊòØLinuxÂü∫Èáë‰ºö‰∏éGSMAÂêà‰ΩúÈ¢ÜÂØºÁöÑÂºÄÊ∫êÈ°πÁõÆ„ÄÇ\nÂÖ®ÁêÉÁßªÂä®Â§ßÂ•ñÔºàGLOMOÔºâÁî±ÁßªÂä®ÈÄö‰ø°Ë°å‰∏öÊùÉÂ®ÅÁªÑÁªáGSMAÂú®1996Âπ¥ÂàõÂäûÔºå2025Âπ¥Êã•ÊúâÂÖ®ÁêÉ260Â§ö‰ΩçÂàÜÊûêÂ∏à„ÄÅÂ™í‰ΩìÂèä‰∏öÂÜÖ‰∏ìÂÆ∂ÁªÑÊàêËØÑÂßîÂõ¢ÔºåÊòØÊúÄÂÖ∑ÊùÉÂ®ÅÁöÑÈÄö‰ø°‰∏öÂ•ñÈ°πÔºåË¢´Ë™â‰∏∫ÁßªÂä®ÈÄö‰ø°‰∫ß‰∏öÁöÑÂ••ÊñØÂç°ÔºåÊó®Âú®Ë°®ÂΩ∞Âú®Âø´ÈÄüÂ¢ûÈïøÁöÑÁßªÂä®Ë°å‰∏öÊé®Âä®ÂàõÊñ∞Âπ∂Â±ïÁé∞Âá∫ÂçìË∂äÊàêÂ∞±ÁöÑ‰∏™‰∫∫ÂíåÂÖ¨Âè∏„ÄÇ",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "chinese",
    "sentiment": "negative",
    "categories": [
      "Environment",
      "Health",
      "Social Issue"
    ],
    "topics": [
      "Health->health care approach",
      "Health->health organisation",
      "Social Issue->social services",
      "Social Issue->diversity, equity and inclusion",
      "Social Issue->social networking"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-03-06T06:01:09.626+02:00",
    "updated": "2025-03-06T06:01:09.626+02:00"
  },
  {
    "uuid": "c5bb3a40ca54539c2b365f1ced205c6ba503f6bf",
    "url": "https://www.ntdtv.com/b5/2025/04/23/a103979224.html",
    "ord_in_thread": 0,
    "author": "ntdtv.com",
    "published": "2025-04-23T23:01:06Z",
    "title": "4Êúà23Êó•Â∑ùÊôÆÊñ∞Êîø Â∑ùÊôÆÁ∞ΩË°åÊîø‰ª§ÊåØËààÊïôËÇ≤ Ë≤°ÊîøÈÉ®Èï∑Êè≠‰∏≠ÂÖ±Á™òÂ¢É | ‰∫∫Â∑•Ëâ≤Á¥† | ‰∏≠ÂÖ±Á∂ìÊøüÂç±Ê©ü | ÁæéÈò≤Èï∑ | Êñ∞Âîê‰∫∫ÁîµËßÜÂè∞",
    "text": "„ÄêÊñ∞Âîê‰∫∫Âåó‰∫¨ÊôÇÈñì2025Âπ¥04Êúà24Êó•Ë®ä„ÄëÈÄ±‰∏âÔºåÂ∑ùÊôÆÁ∏ΩÁµ±Á∞ΩÁΩ≤‰∫Ü‰∏ÉÈ†Ö Ë°åÊîø‰ª§ ÔºåÂÖ∂‰∏≠‰∏ÄÈ†ÖÁâπÂà•ÈáùÂ∞çÊïôËÇ≤ÂíåÁßëÊäÄÊîøÁ≠ñ‰∏ãÈÅîÊñ∞ÊåáÁ§∫ÔºåË¶ÅÊ±ÇÊïôËÇ≤ÈÉ®ËàáÂúãÂÆ∂ÁßëÂ≠∏Âü∫ÈáëÊúÉÂÑ™ÂÖàÊäïÂÖ•Ë≥áÊ∫êÔºåÊé®ÂãïÂ∞ñÁ´ØÁßëÊäÄÈÄ≤ÂÖ•‰∏≠Â∞èÂ≠∏Ë™≤Á®ã„ÄÇÂè¶Â§ñÔºåFDAÂÆ£‰ΩàÔºåÂ∞áÈÄêÊ≠•Ê∑òÊ±∞ÂæûÁü≥Ê≤πÊèêÁÖâÂá∫ÁöÑ‰∫∫Â∑•È£üÁî®Ëâ≤Á¥†„ÄÇËÇØÂ∞ºËø™Ë°®Á§∫ÔºöÊ≤í‰∫∫ÊÉ≥ÂêÉÁü≥Ê≤π„ÄÇ‰ªñ‰∏¶Âº∑Ë™øÔºöÊîøÂ∫úÂ∞áÂä†Âø´ÂØ©Êü•ÈÄüÂ∫¶ÔºåÂÖ®Èù¢ÊèêÂçáÂúãÊ∞ëÈ£≤È£üÂÆâÂÖ®„ÄÇ‰∏ãÈù¢ÊòØ‰ªäÂ§©ÁöÑ Â∑ùÊôÆÊñ∞Êîø „ÄÇ„ÄäÂ∑ùÊôÆÁ∞ΩÁΩ≤7È†Ö Ë°åÊîø‰ª§ ÈóúÊ≥®ÊïôËÇ≤„Äã\nÁæéÈ£üËó•Â±ÄÂÆ£‰ΩàÊ∑òÊ±∞ ‰∫∫Â∑•Ëâ≤Á¥† Ë°õÁîüÈÉ®Ë´áÂç±ÂÆ≥ ÁæéÂúãÈ£üÂìÅËó•ÂìÅÁõ£Áù£ÁÆ°ÁêÜÂ±ÄÈï∑ÈÄ±‰∏âÂÆ£‰ΩàÔºåÈÄêÊ≠•Ê∑òÊ±∞‰∫∫Â∑•È£üÁî®Ëâ≤Á¥†ÔºåËÆìÈ£üÂìÅÊõ¥ÂÅ•Â∫∑„ÄÇ\nÁæéÂúãÈ£üÂìÅËó•ÂìÅÁõ£Áù£ÁÆ°ÁêÜÂ±ÄÈï∑È¶¨ËíÇ¬∑È¶¨Âç°ÈáåÔºö„ÄåÊàëÂÄëË¨πÊÖéË°å‰∫ãÔºåÊ≠£Ë°åÂãïËµ∑‰æÜÁßªÈô§ÁæéÂúãÈ£üÁâ©‰æõÊáâ‰∏≠ÁöÑÔºà ‰∫∫Â∑•Ëâ≤Á¥† Ôºâ„ÄÇ„Äç\nÈÄ±‰∫åÔºåË°õÁîüËàáÂÖ¨ÁúæÊúçÂãôÈÉ®Èï∑ËÇØÂ∞ºËø™ÂÆ£‰ΩàÔºåÂà∞ÊòéÂπ¥Âπ¥Â∫ïÂâçÊ∑òÊ±∞ÂæûÁü≥Ê≤π‰∏≠ÊèêÂèñÁöÑÂêàÊàêËâ≤Á¥†„ÄÇ\nÁæéÂúãË°õÁîüËàáÂÖ¨ÁúæÊúçÂãôÈÉ®Èï∑ Â∞èÁæÖ‰ºØÁâπ¬∑ËÇØÂ∞ºËø™Ôºö„ÄåÊ≤í‰∫∫ÊÉ≥ÂêÉÁü≥Ê≤π„ÄÇÊâÄÊúâ‰∫∫ÈÉΩÁü•ÈÅìÔºåÊúâË∂≥Â§†ÁöÑÁßëÁ†îË≠âÊòéÁü≥Ê≤πÂ∞ç‰∫∫È´îÊúâÂÆ≥„ÄÇ„Äç\nÁõÆÂâçÊ≤íÊúâÊòéÁ¢∫Á†îÁ©∂ÊåáÂá∫Ôºå‰∫∫Â∑•Ëâ≤Á¥†ÂΩ±Èüø‰∫∫È´îÂÅ•Â∫∑„ÄÇ‰ΩÜÂãïÁâ©Ë©¶È©óÁôºÁèæÔºåÊüê‰∫õÈ°îÊñôË∑üÁôåÁóáÂíåËÖ´Áò§Â≠òÂú®ÊΩõÂú®ÈóúËÅØ„ÄÇ\nË°õÁîüÈÉ®Ê≠£Âú®ÂÖ®Èù¢ÊèêÂçáÁæéÂúã‰∫∫ÂÅ•Â∫∑ÔºåË°®Á§∫Â∞áÂä†Âø´ÂØ©Êü•ÔºåÂÑòÊó©Êèê‰æõÂÆâÂÖ®ÁöÑÂ§©ÁÑ∂Ëâ≤Á¥†‰æÜÂèñ‰ª£ÁõÆÂâç‰ΩøÁî®ÁöÑ‰∫∫Â∑•Ëâ≤Á¥†„ÄÇ\nÁæéË≤°Èï∑Ë´áËàáIMFÈóú‰øÇ Êè≠ ‰∏≠ÂÖ±Á∂ìÊøüÂç±Ê©ü ÁæéÂúãË≤°ÊîøÈÉ®Èï∑ÈÄ±‰∏âÂú®ÂúãÈöõÈáëËûçÂçîÊúÉÊºîË¨õÔºåÊè≠Èú≤‰∏≠ÂúãÁ∂ìÊøüÈô∑ÂÖ•Âõ∞Á™ò„ÄÇÂúãÂÖßÊ∂àË≤ª‰ΩéËø∑ÔºåÂåó‰∫¨ÊîøÂ∫úÂú®‰æùÈù†Âá∫Âè£‰æÜÊì∫ËÑ´Âõ∞Â¢ÉÔºåÁÑ∂ËÄåÈÄôÂÄãÊñπÊ≥ï‰∏çÂèØÊåÅÁ∫åÔºåÂè™ËÉΩÂ∞éËá¥Ë≤øÊòìÂö¥ÈáçÂ§±Ë°°Ôºå‰∏çÂÉÖÂÇ∑ÂÆ≥ÂÖ∂ÂÆÉÂúãÂÆ∂ÔºåÊõ¥ÂÇ∑ÂÆ≥Ëá™Â∑±„ÄÇ\nÁæéÂúãË≤°ÊîøÈÉ®Èï∑Ë≤ùÊ£ÆÁâπÔºö„Äå‰∏≠ÂúãÁ∂ìÊøüÁ≥ªÁµ±Âú®‰ª•Ë£ΩÈÄ†Ê•≠Âá∫Âè£ÁÇ∫ÊàêÈï∑ÂãïÂäõÔºåÈÄôÂ∞áÊåÅÁ∫åÈÄ†ÊàêËàáË≤øÊòìÂ§•‰º¥ÈñìÁöÑÊõ¥Âö¥ÈáçÁöÑÂ§±Ë°°„ÄÇ„Äç\nË≤ùÊ£ÆÁâπË™™Ôºå‰∏≠ÂúãÈúÄË¶ÅÊîπËÆäÔºåËÄåÁæéÂúãÂ∏åÊúõËÉΩÂπ´Âä©‰∏≠ÂúãÊîπËÆäÔºå‰ª•Â∞ãÊâæ‰∏ÄÂÄãÂÑ™Ë≥™ÁöÑÂπ≥Ë°°„ÄÇ\nË≤ùÊ£ÆÁâπËß£ÈáãÔºåÁæéÂúãË¶ÅÊ±ÇË≤øÊòìÂÖ¨Âπ≥ÔºåÂúãÈöõÁ∂ìÊøüÈ´îÁ≥ªÂÖ¨Ê≠£Ôºå‰∏çÊòØËÑ´Èõ¢ÂúãÈöõÁµÑÁπîÔºåËÄåÊòØÂ∞ãÊ±ÇÊì¥Â§ßÂ∞çÂúãÈöõË≤®Âπ£Âü∫ÈáëÁµÑÁπî„ÄÅ‰∏ñÁïåÈäÄË°åÁ≠âÊ©üÊßãÁöÑÈ†òÂ∞éÂäõ„ÄÇ\nÁæéÂúãË≤°ÊîøÈÉ®Èï∑ Ë≤ùÊ£ÆÁâπÔºö„ÄåÊàëÊÉ≥ÊæÑÊ∏ÖÔºåÁæéÂúãÂÑ™ÂÖà‰∏çÊòØÊÑèÂë≥ËëóÁæéÂúãË¶ÅÂ≠§Á´ã„ÄÇÁõ∏ÂèçÔºåÈÄôÊòØÂëºÁ±≤Ë≤øÊòìÂ§•‰º¥ÈÄ≤Ë°åÊõ¥Ê∑±Â±§ÁöÑÂêà‰ΩúÔºåÊï¶‰øÉÁõ∏‰∫í‰πãÈñìÂ∞äÈáç„ÄÇ„Äç\nÁæéÈò≤Èï∑ Ë®™Èô∏ËªçÊà∞Áà≠Â≠∏Èô¢ÊºîË¨õÔºöÁæéÂúãÂõû‰æÜ‰∫Ü ÁæéÂúãÂúãÈò≤ÈÉ®Èï∑Êµ∑Ê†ºÂ°ûÊñØÔºåÈÄ±‰∏âÂà∞Ë®™‰ΩçÊñºË≥ìÂ∑ûÁöÑÁæéÂúãÊúÄÂè§ËÄÅËªçÁáü‰πã‰∏ÄÔºöÂç°ËêäÁàæÂÖµÁáüÔºåÂêëÈÇ£Ë£°ÁöÑÁæéÂúãÈô∏ËªçÊà∞Áà≠Â≠∏Èô¢ÁöÑÂ∏´ÁîüÊºîË¨õ„ÄÇ\n‰ªñÁ®±ËÆöÁæéÂúãÂõû‰æÜ‰∫Ü„ÄÇ\nÁæéÂúãÂúãÈò≤ÈÉ®Èï∑Êµ∑Ê†ºÂ°ûÊñØÔºö„ÄåÂú®ÂúãÈò≤ÈÉ®ÔºåÈÄôÊÑèÂë≥Ëëó‰∏çÂÜçÊúâÂπ≤Êìæ„ÄÇ‰∏çÂÜçÊúâÁ§æÊúÉÂ∑•Á®ãÔºõ‰∏çÂÜçÂ¥áÊãúÊ∞£ÂÄôËÆäÈÅ∑Ôºõ‰∏çÂÜçÊúâÈõªÂãïÂù¶ÂÖãÔºõ‰∏çÂÜçÊúâÊÄßÂà•Ê∑∑Ê∑Ü‚Ä¶‚Ä¶„Äç\nÁæéÂúãÂúãÈò≤ÈÉ®Èï∑Êµ∑Ê†ºÂ°ûÊñØÔºö„ÄåÊàëÂÄëÂú®ÂÖ®Á•ûË≤´Ê≥®ÊñºÊàëÂÄëÁöÑ‰ΩúÊà∞‰ΩøÂëΩ„ÄÇ„Äç\nÊñ∞Âîê‰∫∫ÈõªË¶ñÂè∞Ë®òËÄÖ‰ªªÊµ©ÁæéÂúãËèØÂ∫úÂ†±Â∞é",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "chinese",
    "sentiment": "positive",
    "categories": [
      "Education",
      "Politics",
      "Health"
    ],
    "topics": [
      "Education->educational testing and examinations",
      "Education->educational grading",
      "Politics->education policy",
      "Politics->government",
      "Politics->political development",
      "Health->diet",
      "Health->health organisation",
      "Health->government health care"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-24T02:01:06.554+03:00",
    "updated": "2025-04-24T02:01:06.554+03:00"
  },
  {
    "uuid": "07001c963fdbf7cd27c83e2745f5288b2dff9319",
    "url": "https://ameyawdebrah.com/impact-of-the-springboks-success-in-africa",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Ameyaw Debrah",
    "published": "2024-09-05T16:19:00Z",
    "title": "Impact of the Springboks‚Äô Success in Africa",
    "text": "The remarkable success of South Africa‚Äôs Springboks in international rugby has had a profound impact not only within South Africa but across the African continent. Their triumphs, especially their recent victories in the 2019 and 2023 Rugby World Cups, have significantly influenced rugby‚Äôs growth in Africa in terms of participation, viewership, and social unity.\nIncreased Viewership Across the Continent\nThe Springboks‚Äô continued success has helped increase rugby viewership across Africa. Fans eagerly follow rugby scores , particularly during Rugby World Cup tournaments, which attract large audiences in countries that historically had little exposure to the sport.\nIn 2023, for instance, public screenings and social media engagement during the World Cup highlighted how the entire continent celebrated alongside South Africa. The hashtag #StrongerTogether epitomised the pan-African unity brought about by their wins‚Äã.\nCountries like Kenya and Uganda have expanded their domestic leagues and international fixtures to capitalise on rugby‚Äôs growing popularity. The Springboks‚Äô global success has also encouraged African broadcasters to provide more coverage, bringing the sport into more homes.\nBoost in Rugby Participation\nThe Springboks‚Äô success has not only impacted viewership, but has also sparked significant participation in various African countries . Their victories serve as inspiration, particularly for countries with smaller rugby communities such as Namibia, Kenya, and Uganda.\nThese countries have seen a rise in youth involvement in rugby, encouraged by the Springboks‚Äô achievements and the visibility of players like Siya Kolisi, the first black South African captain, and Tendai ‚ÄúThe Beast‚Äù Mtawarira, who hails from Zimbabwe.\nThis surge in interest is also fuelled by the expanding work of Rugby Africa , the continent‚Äôs governing body for the sport. They have harnessed the Springboks‚Äô triumphs to promote grassroots rugby development in African nations, creating pathways for more young talent to emerge.\nSocial and Economic Benefits\nBeyond the sport itself, the Springboks‚Äô victories have helped build social cohesion. In South Africa, rugby has long been a symbol of unity post-apartheid, and these victories have once again galvanised the nation across racial and socio-economic lines.\nEconomically, rugby‚Äôs growing popularity is creating new opportunities for tourism and merchandising in Africa. South Africa‚Äôs hosting of major rugby events attracts international visitors, while brands have increasingly begun to sponsor rugby development programmes across the continent.\nConclusion\nIn summary, the Springboks‚Äô success has had a widespread impact across Africa, inspiring greater rugby participation, increasing viewership, and promoting social unity. Their achievements transcend sport, symbolising African potential on the world stage.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Sport",
      "Human Interest",
      "Social Issue"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [
      "https://sportsnation.co.ug/2023/10/29/rugby-revolution-the-growing-passion-for-rugby-in-uganda/",
      "https://rugby365.com/results/",
      "https://www.voaafrica.com/a/athletes-authorities-speak-on-rugby-growth-celebrate-springboks-historic-win/7337364.html",
      "https://www.southafrica.net/gl/en/trade/press/south-africas-vibrant-sports-tourism-a-field-of-dreams-and-opportunities",
      "https://www.rugbyafrique.com/",
      "https://voaafrica.com/a/athletes-authorities-speak-on-rugby-growth-celebrate-springboks-historic-win/7337364.html",
      "https://rugby365.com/results",
      "https://www.sportsnation.co.ug/2023/10/29/rugby-revolution-the-growing-passion-for-rugby-in-uganda/",
      "https://www.rugby365.com/results/",
      "https://www.rugbyafrique.com",
      "https://southafrica.net/gl/en/trade/press/south-africas-vibrant-sports-tourism-a-field-of-dreams-and-opportunities",
      "https://rugbyafrique.com/",
      "https://sportsnation.co.ug/2023/10/29/rugby-revolution-the-growing-passion-for-rugby-in-uganda"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": [
        {
          "name": "africa",
          "sentiment": "none"
        }
      ]
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null
    },
    "rating": null,
    "crawled": "2024-09-06T00:39:56.681+03:00",
    "updated": "2024-09-06T00:39:56.681+03:00"
  },
  {
    "uuid": "40a459d85cb7f5d5209a7ea7c278d529fae9fa70",
    "url": "https://jamesriverchurch.podbean.com/e/creativity-and-excellence-with-god-bill-johnson",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "James River Church",
    "published": "2024-05-31T23:00:00Z",
    "title": "Creativity and Excellence With God | Bill Johnson",
    "text": "1.5M\nDownloads\n594\nEpisodes\nWelcome to the James River Church podcast where you will find weekly encouraging sermons from Pastor John Lindell and others! James River Church is one church in multiple locations in the Southwest Missouri area. To learn more, visit jamesriver.church. James River Church, led by Pastors John and Debbie Lindell, is one church in four locations in southwest Missouri, with additional campuses online. The church is passionate about making everyone connected to James River Church feel welcomed home through inspiring worship services and high-energy kids and youth programs. The leadership at James River Church is dedicated to teaching the whole Word of God through engaging, expository preaching. We pray these messages are a blessing and encouragement to your life as God reveals His truth to you through the good news of the Gospel!\nEpisodes\n2 hours ago\n2 hours ago\nIn this exclusive message from Week of Power, guest Pastor Bill Johnson shares about the creativity and excellence that comes when walking with God. Our prayer is you would be encouraged in your walk with God, as God fills you with creative excellence!",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Religion and Belief",
      "Human Interest"
    ],
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "bill johnson",
          "sentiment": "negative"
        },
        {
          "name": "john lindell",
          "sentiment": "none"
        },
        {
          "name": "word of god",
          "sentiment": "none"
        },
        {
          "name": "john",
          "sentiment": "none"
        },
        {
          "name": "debbie lindell",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "james river church",
          "sentiment": "negative"
        },
        {
          "name": "week of power",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "missouri",
          "sentiment": "none"
        },
        {
          "name": "southwest missouri",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-06-01T03:34:27.552+03:00",
    "updated": "2024-06-01T03:34:27.552+03:00"
  },
  {
    "uuid": "7ea7fb66b7ded2f604986c18200247b52775c34d",
    "url": "https://www.indiehackers.com/post/my-2023-recap-60-growth-86407307db",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Daniel Pirciu",
    "published": "2023-12-28T00:00:00Z",
    "title": "My 2023 Recap: +60% Growth",
    "text": "2023 was my 2nd year of freelancing full-time, and things have improved significantly. My breakthrough is that client quality trumps quantity 24/7. Since 2019, when I began my freelance journey, I didn't dare to go all in until last year, doing true independent consulting, aka freelancing, working with multiple clients on multiple projects. Now that I have passed the ‚Ç¨100k in total revenue milestone from independent work, I can say what drives most of my success: working with quality clients vs. wannabe entrepreneurs. A little over ‚Ç¨100k in total revenue from freelancing ‚òù In 2019, I had a few side projects, and then, in 2020 and 2021, I was a full-time employee, so there was no time for playing around. In mid-2021, I said I had to try it and switched from full-time employee to full-time independent consultant. My biggest mistake was working with one client at a time. That led to 2-3 months \"commitments.\" Most were local entrepreneurs with little to no knowledge of running and growing a business. How the number of clients progressed over the years ‚òù So the hard lesson I learned last year is to have one or a maximum of 2 big clients that you can focus on, build a human connection, and deliver quality work, and a few smaller retainers (2 to 3 clients maximum). This year, 50% of my income came from one client; it's a steady, small agency run by two very successful and great leaders I've been working with since the beginning of the year (bye-bye, 3-month entrepreneurs). Almost 25% of my income came from a no-code SaaS I love working with. The average contract a SaaS has with independent contracts is relatively low, so I'm aware that this can end anytime soon. The other 25% came from a local marketing agency and a few smaller projects. Here is another mistake ... months with no payment. Total revenue in 2022 ‚òù Last year, I had two months with zero revenue. I had to slightly overcharge in the following months to compensate for this loss. I learned my lesson; I only had one month with no revenue this year. Total revenue in 2023 ‚òù I noticed that January started quite shy, but the next couple of months made up for it, so it wasn't a big deal, more time with my family. With a new baby coming in mid-January, I expect the same slow growth at the beginning of the year but solid growth starting in March.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Lifestyle and Leisure",
      "Economy, Business and Finance"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2023-12-29T02:06:09.181+02:00",
    "updated": "2023-12-29T02:06:09.181+02:00"
  }
]